- |||||||||| budesonide / Generic mfg.
Review: Quantitative comparison of different inhaled corticosteroids in the treatment of asthma in children. (Pubmed Central) - May 14, 2022 This study analyzed the entire time-course of the drug efficacy of Inhaled corticosteroids in the treatment of asthma in children aged 5-12, which found that although the maximum efficacy of both ciclesonide and budesonide was the same, the onset speed of ciclesonide was faster than that of budesonide. The above information provides the necessary quantitative information for the implementation of medication guidelines for steps 2-3 asthma in children.
- |||||||||| budesonide / Generic mfg., methotrexate / Generic mfg.
Journal: Gastrointestinal Conditions: Inflammatory Bowel Disease. (Pubmed Central) - May 12, 2022 Surgery (complete resection of involved colon) can be curative in UC. In CD, surgery typically is only used for complications or refractory disease.
- |||||||||| Tarpeyo (budesonide) / Calliditas, Stada
NEFECON® (BUDESONIDE) IS AN EPIGENETIC MODIFIER IN IGA NEPHROPATHY (Hall S03) - May 5, 2022 - Abstract #ERAEDTA2022ERA_EDTA_561; P2 Treatment with Nefecon ® 16 mg/day for 9 months selectively downregulated exosomal miR-122-5p, while having no effect on exosomal miR-483-5p levels, arguing against a generalized ‘anti-miR’ effect of Nefecon ® . Studies are ongoing to both precisely delineate the cellular source(s) of these exosomes and determine the downstream impact of these changes on glomerular and tubulointerstitial biology.
- |||||||||| budesonide / Generic mfg.
Journal, IO biomarker: Interplay between nuclear factor-κB, p38 MAPK and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells. (Pubmed Central) - Apr 27, 2022 Here, we explore synergy occurring between synthetic glucocorticoids (dexamethasone and budesonide) and proinflammatory cytokines (IL1B and TNF) on the expression of the toll-like receptor 2 (TLR2)...We conclude that glucocorticoid-plus-cytokine-driven synergy at TLR2 involves GR and NF-κB acting via specific enhancer regions, which combined with inhibition of p38α MAPK promotes TLR2 expression. Subsequent inflammatory effects that occur following TLR2 agonism may be pertinent in severe neutrophilic asthma or chronic obstructive pulmonary disease, where glucocorticoid-based therapies are less efficacious.
- |||||||||| budesonide / Generic mfg.
Journal: Continuous flow process for preparing budesonide. (Pubmed Central) - Apr 26, 2022 In another aspect, particle size optimization studies are also performed to get the desired budesonide solid product. A continuous flow process for preparation of budesonide is identified from the present research investigation which can be readily transferred to industrial scale up.
- |||||||||| Veramyst (fluticasone furoate nasal spray) / GSK
Clinical, Review, Journal: Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature. (Pubmed Central) - Apr 20, 2022 The inhaled glucocorticoids administered were: fluticasone propionate (7 studies), budesonide (6 studies), mometasone furoate (3 studies), beclomethasone dipropionate (1 study), triamcinolone acetonide (1 study), and fluticasone furoate (1 study) respectively. Only 3 out of the 19 trials identified in our narrative review reported data on diabetes mellitus, and in these the incidence of diabetes mellitus was not significantly different in both treatment arms (inhaled glucocorticoids and placebo), regardless of the type of glucocorticoid used.
- |||||||||| budesonide / Generic mfg.
Clinical, Review, Journal: Review of efficacy of ciclesonide for the treatment of asthma in children. (Pubmed Central) - Apr 19, 2022 In children with asthma, once-daily CIC significantly improved large and small airway function, asthma symptoms, and asthma control, and reduced rescue medication use compared with placebo. CIC was comparable with other ICS used to treat asthma in children, which demonstrated its worth for the pediatric population.
- |||||||||| budesonide / Generic mfg., fluticasone / Generic mfg.
Clinical, Review, Journal: Safety of ciclesonide in children with asthma: A review of randomized controlled trials. (Pubmed Central) - Apr 19, 2022 Data from 13 studies demonstrate that CIC is associated with low rates of oropharyngeal AEs, with no indication of clinically relevant systemic effects in children with asthma. The favorable safety profile and demonstrated improvements in asthma control make CIC an ideal inhaled corticosteroid for the treatment of asthma in children.
- |||||||||| budesonide / Generic mfg.
Journal: Budesonide capsules for peristomal pyoderma gangrenosum. (Pubmed Central) - Apr 15, 2022 The results of measuring the 22S epimer content by qNMR are comparable with the results of measurements using the reference HPLC method. No abstract available
- |||||||||| Tarpeyo (budesonide) / Calliditas, Stada
Journal: First Drug to Reduce Proteinuria in Berger's Disease. (Pubmed Central) - Apr 14, 2022 Budesonide (Tarpeyo) has received accelerated approval to reduce proteinuria in adults with primary immunoglobulin A nephropathy, also known as Berger's disease.Nurses should assess if any coprescribed drugs could induce a drug-drug interaction via the cytochrome P-450 isoenzyme system. Because budesonide causes immunosuppression, patients are at high risk for developing infections and should be told to avoid anyone who is known to have an infection.
- |||||||||| budesonide / Generic mfg.
Review, Journal: Current treatment of IgA nephropathy. (Pubmed Central) - Apr 5, 2022 Beyond corticosteroids, there is little evidence that any additional immunosuppression is helpful, with the exception of mycophenolate mofetil in patients of Asian descent. A considerable number of clinical trials ranging from enteric coated budesonide to blockade of B-cell function to complement inhibitors are currently ongoing and will hopefully allow a more targeted therapy of high-risk patients with progressive IgAN in the future.
- |||||||||| zidovudine / Generic mfg., budesonide / Generic mfg.
Journal: Seawater fungi-derived compound screening to identify novel small molecules against dengue virus NS5 methyltransferase and NS2B/NS3 protease. (Pubmed Central) - Apr 5, 2022 Both licensed medications, estramustine (DB01196) and quinestrol (DB04575), were found to be similar to Chevalone E, with prediction scores of 0.818 and 0.856, respectively. In addition, cholic acid (DB02659), acitretin (DB00459), and mupirocin (DB00410) are similar to Sterolic acid, zidovudine (DB00495), imipenem (DB01598), and nadolol (DB01203) are similar to Brocazine A, and budesonide (DB01222) and colchicine (DB01394) are related to Brevione K. These findings suggest that these could be feasible dengue virus treatment options, meaning that more research is needed.
- |||||||||| budesonide / Generic mfg.
Journal: Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant. (Pubmed Central) - Mar 23, 2022 A subset of glucocorticoid-regulated biochemicals is associated with lung inflammatory status as assessed by lung fluid cytokine concentration. Lower doses of budesonide in surfactant than currently used may provide adequate anti-inflammatory responses in the lung with fewer systemic effects, improving the benefit:risk ratio.
|